key: cord-0837340-85hcpbg2 authors: Hernández-Rivas, Lucía; Pedraz, Teresa; Calvo, Cristina; Juan, Isabel San; José Mellado, Mª; Robustillo, Ana title: Respiratory syncytial virus outbreak DURING THE COVID-19 PANDEMIC. How has it changed? date: 2021-12-22 journal: Enferm Infecc Microbiol Clin DOI: 10.1016/j.eimc.2021.12.003 sha: 5feb6e22dd48cad92927ec72ac43fc7f508b218d doc_id: 837340 cord_uid: 85hcpbg2 Introduction: The epidemiology of respiratory syncytial virus (RSV) infection has changed during the COVID-19 pandemic. Our objectives were to describe the RSV epidemic in 2021 and compare it with the previous years to the pandemic. Methods: Retrospective study performed in Madrid (Spain) in a large paediatric hospital comparing the epidemiology and clinical data of RSV admissions during 2021 and the two previous seasons. Results: 899 children were admitted for RSV infection during the study period. During 2021, the outbreak peaked in June and the last cases were identified in July. Previous seasons were detected in autumn-winter. The number of admissions in 2021 was significantly lower than in previous seasons. There were no differences between seasons regarding age, sex or disease severity. Conclusion: RSV hospitalizations during 2021 in Spain moved to summer with no cases in autumn and winter 2020-2021. Unlike other countries, clinical data were similar between epidemics. Respiratory syncytial virus (RSV) is the most prevalent viral cause of bronchiolitis and lower respiratory tract infection and hospitalization in infants worldwide. Estimates The COVID-19 pandemic has drastically changed the epidemiology of other viral respiratory infections in both children and adults. Worldwide, the autumn and winter RSV epidemics have virtually disappeared 3, 4 , and in some countries in the Southern hemisphere like South Africa or Australia, the RSV season has moved to spring, marking an unprecedented phenomenon 5 . In Spain, as in other European countries, the winter epidemic (November-February) has disappeared and moved to springsummer 6 . Although the increased absenteeism to day care centres and the nonpharmacological measures used to combat the COVID-19 pandemic will have contributed to modify the seasonal pattern, there are other theories about what may be behind these epidemiological changes. In addition, other viruses such as rhinoviruses have remained causative agents of respiratory infections and bronchiolitis 7 . RSV has not circulated for more than one year and pregnant women have not acquired natural immunity as a result of prolonged absence of contact, which could mean a change in the severity of the infection in young infants. The objective of this study is to describe the epidemiological characteristics of the delayed 2021 RSV epidemic in Spain and compare them with those of previous winter seasons in a paediatric tertiary care hospital. This is a retrospective study including all patients under 18 years hospitalized for RSV during two conventional pre-COVID-19 epidemic seasons -2018-2019 and 2019-2020 J o u r n a l P r e -p r o o f Spain. We consider the 2021 epidemic to be over by July 31, as the number of incident cases in our centre practically disappeared. In our hospital, rapid test and/or PCR for RSV (Alere i or COBAS Liat, Roche®) is systematically performed in paediatric patients needing admission with compatible symptomatology during the epidemic season. During the 2020-2021 season, the same criteria were followed. When the regional surveillance systems detected the first positive cases in 2020, systematic screening was established in our centre. During the 2021 season we registered 181 hospitalizations. 55.8% of the patients were male and mean age was 9 months (SD 12.4). Median length of hospital stay was 5 days (IQR 4-8). PICU admission rate was 30.9%, with median length of stay in PICU of 3 days (IQR 2-5). Median age of patients admitted to PICU was 1 month (IQR 0-3), while those who did not required PICU admission were older, with median age 7 months (IQR 1-16; p-value <0.001). Three cases were hospital-acquired (1.7%), which were diagnosed more than 5 days after admission and had no symptoms on admission. Patients' characteristics had a similar distribution in the three studied seasons, no significant differences were observed between them (Table 1 ). Our study showed changes in the epidemiology of RSV hospitalizations during 2021 in Spain, with an onset of cases in spring and no cases in autumn and winter 2020-2021. In addition, the weekly number of admissions registered during 2021 epidemic was lower than previous years, although the clinical characteristics of the patients were similar. This temporal shift was reported in other studies, although their incidence was higher and even exceeded that of preceding years 8, 9 . A study from Australia also found an increase in patients' median age 9 and other work from the United States reported a more severe course of the infection 10 . In contrast, we did not find differences with previous epidemic seasons regarding age, sex or disease severity. A potential bias of our study is that we only included hospitalized patients. Therefore, we lack information related to mild cases that are more likely handled in primary health care. Because of this, our results cannot be widely generalized. Nevertheless, the fact that our study was conducted in a tertiary hospital including data on all RSV infection hospitalizations during three epidemic seasons, collected as part of surveillance activities existing prior to the COVID-19 pandemic allows for a big sample size which, despite the limitations, we believe is representative of the RSV hospitalized Madrid population. As other various infectious diseases, RSV has been impacted by the COVID-19 pandemic. Our data confirms the change in seasonality reported in other studies around the world and remarks the importance of surveillance systems in order to study disease dynamics and plan ahead the potential implications for medical services. Viral Viral bronchiolitis Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Impact of SARS-CoV-2 pandemic on bronchiolitis hospitalizations: the experience of an Italian tertiary center Acute bronchiolitis during the COVID-19 pandemic Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses Vigilancia centinela de infección respiratoria aguda en atención primaria (IRAs) y en hospitales (IRAG) Gripe, COVID-19 y otros virus respiratorios.; 2021 Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-A nationwide register study in Finland Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures Delayed seasonal RSV surge observed during the COVID-19 pandemic Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter COVID-19 public health measures and respiratory syncytial virus Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) Interference between respiratory syncytial virus and human rhinovirus infection in infancy Bronchiolitis in COVID-19 times: a nearly absent disease?